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Alcohol use disorders generate considerable cost to society and the
health system in particular. In the UK it is estimated that alcohol
use disorders are linked to 22 000 premature deaths and cost the
economy £20 billion annually.1 A recent national alcohol needs
assessment found that over 7 million adults in England are
hazardous or harmful drinkers and a further 1.1 million are
alcohol dependent.2 Alcohol is a leading cause of morbidity and
mortality, and reducing alcohol-related harm is a key priority of
the UK government with publication of the National Alcohol
Harm Reduction Strategy3 and the Choosing Health White Paper.4
There are now 13 meta-analyses and/or systematic reviews of
brief alcohol interventions, including five specifically focused on
primary care.5–9 The greatest evidence of efficacy is in populations
identified in primary care settings. Overall, there is a 20–30%
reduction in alcohol consumption following brief intervention
compared with control conditions, and several studies have found
significant reductions in healthcare utilisation in the brief
intervention group. One review of 34 brief intervention studies
indicates that brief interventions are only more effective than
control conditions in people who drink excessively identified by
opportunistic screening rather than in those seeking alcohol
treatment.10
Among this wealth of positive evidence regarding efficacy
there is also some ambivalence towards the effectiveness of brief
interventions. Heather11,12 suggests that brief interventions
delivered in naturalistic settings would probably have smaller
effects than efficacy studies tend to suggest. Edwards & Rollnick13
suggest we should exercise some caution in generalising from
efficacy studies to effectiveness. Studies of efficacy often have
systematic biases associated with the population under study
and tend to be an evaluation of an intervention delivered by
motivated practitioners. An appropriate methodology for
evaluating effectiveness should involve a pragmatic balance
between internal and external validity providing a better
indication of ‘naturalistic effectiveness’. Howard14 also noted the
limitations in rigorous economic evaluations in the area of brief
interventions – there is a clear need for pragmatic randomised
clinical trials of brief interventions that address effectiveness and
cost-effectiveness aspects of brief interventions.
A further problem with the research literature on brief
interventions stems from the varying definitions of interventions
used in different studies.11,15 What is considered a brief inter-
vention in one study is considered an extended intervention in
another. A number of reviews and meta-analyses fail to take this
intervention heterogeneity into account.11,16
Screening for alcohol use disorders identifies a wide range of
needs, varying from hazardous and harmful drinking to severe
alcohol dependence, that are likely to require a range of types
and intensities of treatment. Stepped care interventions offer a
potentially resource-efficient means of meeting the needs of
individuals in more severe cases. Stepped care provides a means
of delivering high-intensity and more costly interventions only
to those who fail to benefit from less intensive interventions, more
in keeping with the way clinical care is typically delivered than the
application of blanket brief interventions. Further, evidence from
surveys of primary care practitioners highlights a reluctance to
implement brief interventions, in part because they lack the skills
to deal with the more severe cases identified.17 Stepped care
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Background
Screening for alcohol use disorders identifies a wide range of
needs, varying from hazardous and harmful drinking to
alcohol dependence. Stepped care offers a potentially
resource-efficient way of meeting these needs, but requires
evaluation in a randomised controlled trial.
Aims
To evaluate the feasibility, effectiveness and cost-
effectiveness of opportunistic screening and a stepped care
intervention in primary care.
Method
A total of 1794 male primary care attendees at six practices
in South Wales were screened using the Alcohol Use
Disorders Identification Test (AUDIT). Of these, 112
participants who scored 8 or more on the AUDIT and who
consented to enter the study were randomised to receive
either 5 minutes of minimal intervention delivered by a
practice nurse (control group) or stepped care intervention
consisting of three successive steps (intervention group): a
single session of behaviour change counselling delivered by
a practice nurse; four 50-minute sessions of motivational
enhancement therapy delivered by a trained alcohol
counsellor; and referral to a community alcohol treatment
agency.
Results
Both groups reduced alcohol consumption 6 months after
randomisation with a greater, although not significant,
improvement for the stepped care intervention. Motivation to
change was greater following the stepped care intervention.
The stepped care intervention resulted in greater cost
savings compared with the minimal intervention.
Conclusions
Stepped care was feasible to implement in the primary care
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approaches have gained acceptance in the smoking cessation
field,18,19 as well as other areas of medicine such as hypertension
treatment, but they also represent an important development in
the alcohol treatment field.20,21
Stepped care provides a pragmatic clinical algorithm that
addresses the needs of a spectrum of alcohol use disorders and
provides appropriate interventions for those who fail to benefit
from brief interventions. This is a pragmatic pilot study to assess
the feasibility, effectiveness and cost-effectiveness of a stepped care




A prospective pragmatic randomised controlled trial in which
eligible consenting participants where randomised with equal
probability to either stepped care or minimal intervention.
Randomisation was conducted remote from the research centres
by the trial randomisation service at the University of York. Block
randomisation with seeded random elements was used to
minimise the possibility of subversion. Follow-up was conducted
at 6 months post-randomisation by a researcher masked to the
allocated group.
Sample size
The closest study of opportunistic screening and intervention in a
UK primary care population is that of Wallace et al.22 In this study
the standardised effect size between intervention and control was
0.36 for males. To replicate this effect requires 177 participants to
gain 80% power to detect a difference at the 5% significance level.
Assuming that only 75% will be followed up at 6 months inflates
this figure to 236, 118 in each randomised group. However, we
managed to recruit 112 individuals in total in the time available.
So this is best regarded as a pilot study to establish feasibility
and to determine the effect size on which to power a larger study.
Participants
Participants were consecutive male attendees at six primary care
practices in South Wales. Females were excluded since at the time
of designing the trial meta-analyses suggested smaller effect sizes
of brief alcohol interventions in women than in men, which would
have required a much larger sample size than the funding for the
study would allow. However, subsequent research suggests
equivalence of outcomes in males and females, and our ongoing
research (see below) includes both genders.
Eligible male patients were aged 18 years or more, had a self-
completion Alcohol Use Disorders Identification Test (AUDIT)23
score 58 and/or a diagnosis of an alcohol use disorder assessed
using ICD–10 criteria at baseline assessment (using the CIDI
Alcohol Use Disorders interview24 conducted by the research
assessor) and/or were drinking above Department of Health
guidelines for hazardous drinking as assessed by the Time Line
Follow Back25 measure of alcohol consumption (see below)
(421 units/week or 48 units/day), lived within commuting
distance of the primary care practice, had not received treatment
for an alcohol use disorder in the previous 180 days and were
willing to consent to receive either treatment and take part in
follow-up assessments.
Patients were not eligible if they had a primary drug
dependence other than alcohol, suffered from a severe mental or
physical illness, severe cognitive impairment or had legal issues
that might have interfered with follow-up.
Procedure
Patients attending primary care practices were asked by a practice
nurse to complete an AUDIT questionnaire embedded within a
general lifestyle questionnaire, which was scored by the practice
nurse. Any patient who scored 8 or more was then provided with
an information sheet about the study and asked if they would
consider taking part. Those willing to participate were offered
an appointment with the research assessor within 1 week of
screening.
At the initial research assessment, eligibility criteria were
established and those eligible invited to consent to participation
in the study. Those who were eligible and consented were
randomised using the remote randomisation service at the
University of York and allocated to either stepped care
(intervention group) or minimal intervention (control group).
Six months after randomisation, patients were contacted by
the research assessor, who made an appointment for a follow-up




Patients received a 5-minute directive advice session from a
practice nurse addressing the need for them to reduce their
alcohol consumption. Patients also received a short self-help
booklet outlining the consequences of excessive alcohol
consumption and including details on where to seek help locally
for alcohol problems.
Intervention group
Patients received a sequential series of interventions according to
need and response after each successive step.
Step 1. All patients randomised to this group were offered a
40-minute session of behaviour change counselling26 from a
trained practice nurse. Each patient was invited for follow-up with
the same nurse 28 days after the initial session. Patients who had
consumed 421 units of alcohol in any one week or 410 units
in any one day during the 28-day period were referred to step 2.
Step 2. All patients referred to step 2 were offered a maximum of
four 50-minute sessions of motivational enhancement therapy27
conducted by a trained alcohol counsellor. Sessions were held at
the primary care practice and scheduled for one per week over a
4-week period. Each patient was invited for a follow-up with
the practice nurse 28 days after the final session. Patients who
had consumed 421 units in any one week or 410 units in any
one day in the 28-day period were referred to step 3.
Step 3. Patients were referred to the local community alcohol
team for specialist intervention. There was no limit on duration
or intensity of treatment, which could encompass, where
necessary, detoxification, in-patient treatment, out-patient
counselling, relapse prevention and drug therapy. The clinical
protocol included a caveat that any patient in the intervention
group who needed urgent referral to step 3 at any stage could
be referred without going through intermediate care steps.
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The primary outcome measure was alcohol consumption as
measured over 180 days using the Time Line Follow Back
method.25 This method generates three outcomes: total alcohol
consumed in the period, mean number of drinks per drinking
day and percentage of days abstinent.
Secondary outcomes
Motivation was measured using the Readiness to Change
Questionnaire (RTCQ),28 specifically designed to assess stages of
change in opportunistic brief interventions for people who drink
excessively. The 12-item RTCQ allocates scores for each of three
stages of change: pre-contemplation, contemplation and action.
Scores range from –10 (pre-contemplation) to +10 (action).
Alcohol dependence was measured using the Severity of
Alcohol Dependence Questionnaire,29 which addresses five
components of alcohol dependence: physical withdrawal, affective
withdrawal, withdrawal relief, alcohol consumption and rapidity
of reinstatement. The instrument is self-completed and provides
a severity score ranging from 0 (no dependence) to 60 (very severe
dependence).
Alcohol-related problems were measured using the Alcohol
Problems Questionnaire (APQ).30 The APQ contains 44 items
across eight problem domains (friends, money, police, physical,
affective, marital, children and work). The first 23 items are
applicable to all individuals and are referred to as the ‘common’
subscale. This subscale ranges from 0 (no problems) to 23 (many
problems).
Self-efficacy was measured using the Situational Confidence
Questionnaire.31 This questionnaire assesses an individual’s confi-
dence to resist the urge to drink in a variety of situations. The
overall score provides a range from 0 (not at all confident) to
100 (very confident).
Quality of life was measured using an established generic
quality-of-life measure, the Short Form–12 (SF–12).32 The SF–12
generates two component scores relating to physical and mental
health. The scores are standardised and norm-based on UK
populations. The scores range from 0 to 100 with a standardised
population mean of 50.
Economic evaluation
The economic evaluation involved four different components: the
costs of training; the costs of the interventions; changes in social
costs; and changes in quality-adjusted life-years (QALYs). The
costs of training and interventions were derived from therapist
and participant take-up recorded at the time of the trial. Local
costs of salaries, overheads and premises were used with the
take-up data to estimate costs. We calculated participant social
costs from a specifically designed questionnaire to ascertain
healthcare, social care and accident-related service utilisation
along with criminal offences committed 6 months prior to and
6 months after randomisation. Unit costs were derived from
national references for service utilisation33,34 and government
sources for the cost of crime.35 Health outcomes were assessed
using QALYs using the EQ–5D at baseline and 6 months with
population values.36–38 The EQ–5D is a generic instrument that
measures health on five scales (mobility, self-care, usual activities,
pain and discomfort, anxiety and depression).
Analysis
Owing to the pragmatic design of the trial, analysis was conducted
as an intention-to-treat analysis whereby participants were ana-
lysed according to the group they were allocated to rather than
the treatment they received. Comparison between groups at 6
months was adjusted using analysis of covariance (ANCOVA) to
take into account variability in corresponding baseline scores.
From the economic data we calculated the net costs of stepped
care and minimal intervention (treatment costs less any difference
in social costs at 6 months compared with baseline social costs).
Quality-adjusted life-years were calculated for both interventions
measuring the area under the curve joining the points at baseline
and 6 months.37 As economic data tend to be skewed, we used
bootstrapping techniques to obtain more reliable confidence
interval estimates. As the assumptions required to use analysis
of covariance are not assumed to hold with these economic data,
we followed the advice of Vickers,39 who suggests that comparing
baseline less follow-up values for both intervention groups is an
acceptable alternative. We divided the differences in the net costs
of interventions by the difference in QALY gains to yield the
incremental cost-effectiveness ratio. We estimated the sampling
distribution of this ratio from 1000 bootstrapped samples and
derived cost-effectiveness acceptability curves.40 These curves plot
the resulting probability that one intervention is better than the
other against the maximum decision makers might pay for an
additional QALY.
Analysis was conducted using SPSS version 13 for Windows
and STATA version 10 for Windows.
Results
Sample characteristics
A total of 1794 male primary care attenders were screened at six
primary care practices in South Wales. All patients approached
by the practice nurse completed the screening questionnaire. Of
these, 447 (25%) scored positive for an alcohol use disorder
(AUDIT 58), all of whom met the eligibility criteria to take
part in the study. Overall, 112 (25%) gave consent and were
randomised: 54 to the intervention group and 58 to the control
group. Those consenting to take part were older (mean 42.7 years
v. 37.7 years) and had higher AUDIT scores (mean 13.7 v. 11.9).
All participants randomised to the control group received
minimal intervention and 96% (52/54) of those randomised to
the intervention group received step 1. A further 31% (17/54) of
the intervention group were referred on for step 2 and only one
participant was referred on to step 3 for detoxification. In the
latter case this occurred on presentation for step 1 because of
symptoms of severe alcohol withdrawal.
Of those who were randomised, 81% were followed up at 6
months, 90% in the control group and 72% in the intervention
group; Fig. 1 shows the full CONSORT diagram for the study. A
total of 81% follow-up is acceptable for alcohol research studies.
The average age of participants was 43 years and they had
drunk alcohol on average 62% of the previous 180 days,
consuming on average 14 units of alcohol per drinking day
(1 unit = 8 g ethanol). Both groups were evenly matched on
demographics, primary and secondary outcomes at randomisation
(Table 1).
Primary outcomes
At 6 months both groups had reduced their consumption con-
siderably from baseline (Table 2). Greater reduction was observed
in the intervention group in terms of total alcohol consumed
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(7408.6 g v. 7238.8 g) and drinks per drinking day (72.4 v.
71.0) with an adjusted mean difference of 145.6 (95% CI
7101.7 to 392.9) and 1.1 (70.9 to 3.1) (Table 3) respectively.
This difference was not significant at the 0.05 level, but the
standardised effect sizes for drinks per drinking day and total
alcohol consumed were comparable with previous studies of brief
intervention (0.27 and 0.23 respectively).
Secondary outcomes
At 6 months both groups had a slight increase in attributes
associated with precontemplation (intervention group 0.5 v.
control group 0.5), contemplation (0.1 v. 0.1) and action (2.7 v.
0.8) stages of change. Adjusted analysis indicates that the mean
difference between the groups showed that the control group
had a greater level of precontemplation (–0.2; 95% CI –1.7 to
1.1) and contemplation (–0.3; 95% CI –1.7 to 1.1) but that the
intervention group scored higher on action (1.8; 95% CI 0.2–
3.3), which was significant at the 0.05 level.
Alcohol-related problems and dependence decreased and self-
efficacy increased in both groups, but none of these was significantly
different between groups. No significant differences in quality of
life or mental health were seen between groups at follow-up.
Economic outcomes
The cost assumptions are shown in Table 4. In the control group
participants received 5 minutes of brief advice and a self-help
booklet. Using 2001 prices33 the cost per minute of practice nurse
time is £0.22; this includes salary, employer’s National Insurance,
superannuation and an 8% management overhead. We also add
premises costs, at £0.54/m2 per hour, assuming a room of 8m2,
and the cost of the booklet at £0.13. Thus, the total cost for the
minimal intervention is £1.59.
In step 1 of the stepped care intervention participants received
40 minutes of motivational interviewing delivered by a practice
nurse, at a cost of £12.74 including salary and premises costs. This
was followed by a telephone call 2 weeks later, estimated to last
1.5 minutes at a cost of £0.68. A month after the motivational
interview the practice nurse conducted an interview with the
participant to assess their current alcohol consumption – this
was estimated to take 10 minutes at a cost of £3.18 including staff
and premises costs. The total cost of step 1 was estimated at £16.60
per participant.
Step 2 consisted of four 50-minute sessions of motivational
enhancement therapy delivered by a trained alcohol counsellor.
Sessions attended were costed using full salary costs, including
overheads and a management cost of 8% of salary. The cost of
the 8m2 room was added together with a 10-minute administra-
tion time cost. Two weeks after step 2, a 5-minute telephone call
was made to the participant at a cost of £1.30. Costs associated
with extra telephone calls and letters were recorded and included
in the analysis. For sessions where the participant failed to attend a
scheduled session, a 5-minute cost was included on the basis that
therapists use the time to engage in other tasks.34
Step 3 costs are associated with only one participant and no
specific data were available on treatments received within the




Eligible for trial, n = 447
Consented, n = 112
AUDIT negative, n = 1347
Refused consent, n = 335
Randomised to minimal
intervention, n = 58
Received minimal intervention,
n = 58
Followed-up at 6 months, n = 52
Refused follow-up assessment, n = 6
Randomised to stepped care,
n = 54
Received step 1, n = 52
Received step 2, n = 17
Received step 3, n = 1
Followed up at 6 months, n = 38
Lost at follow-up, n = 15
In prison, n = 2
Deceased, n = 1












Fig. 1 CONSORT diagram for the study. AUDIT, Alcohol Use Disorders Identification Test.
Drummond et al
In addition to treatment costs, 1794 participants were
screened to identify 112 eligible and consenting participants.
The cost of general lifestyle questionnaires and 5 minutes of
practice nurse time to interpret the questionnaires is included
for all 1794 screened participants divided by 112 consenting
participants to arrive at a screening cost of £18.30 per participant.
Further, in order to deliver motivational interviewing, practice
nurses were trained and supervised at a total cost of £8000 divided
by the 54 participants in the intervention group to arrive at a
training cost of £148.15 per participant. It is possible that the
training costs for stepped care are overestimated in that staff
trained to deliver stepped care can continue to apply these skills
after the trial is completed. However, as we have no way of know-
ing how far this would be applied after the trial was completed
and all of the staff were redeployed to other posts after the end
of the study, we have made a conservative estimate of the training
costs in terms of cost-effectiveness.
Social costs for each group at baseline and 6 months are re-
ported in Table 5 along with estimated treatment costs, including
training, for patients with follow-up data only. The social costs
include healthcare and social care costs, and costs associated with
accidents. Crime costs are based on the estimated cost per offence,
452
Table 1 Mean (s.e.) participant demographics, and primary and secondary outcomes at baseline
Intervention group (n=54), mean (s.e.) Control group (n=58), mean (s.e.)
Age, years 41.4 (2.3) 42.1 (1.9)
AUDIT scorea 13.6 (0.8) 13.3 (0.7)
Alcohol consumption (previous 180 days)
Total number of drinks consumed in periodb
Drinks per drinking dayb

















Alcohol Problems Questionnaired 5.6 (0.6) 4.7 (0.4)
Severity of Alcohol Dependence Questionnairee 8.2 (0.9) 8.8 (1.2)
Situational Confidence Questionnairef 72.8 (18.0) 74.9 (17.8)







AUDIT, Alcohol Use Disorders Identification Test; SF–12, Short Form–12.
a. Scores from 0 (low) to 40 (high).
b. One standard drink = 1 unit = 8 g of ethanol.
c. Scores from 710 (low) to +10 (high).
d. Alcohol Problems Questionnaire, common scale; scores from 0 (low) to 23 (high).
e. Scores from 0 (low) to 60 (high).
f. Scores from 0 (low) to 100 (high).
g. Scores from 0 (low) to 100 (high).
Table 2 Mean (s.e.) participant primary and secondary outcomes change at 6 months from baseline
Intervention group (n=39), mean (s.e.) Control group (n=52), mean (s.e.)
Alcohol consumption (previous 180 days)
Total number of drinks consumed in perioda
Drinks per drinking daya

















Alcohol Problems Questionnairec 71.5 (0.3) 71.1 (0.4)
Severity of Alcohol Dependence Questionnaired 71.5 (0.6) 71.2 (0.8)
Situational Confidence Questionnairee 3.0 (1.6) 2.3 (1.5)







Health utility (EQ–5D)g 50.1 (0.1) 50.1 (0.1)
a. One standard drink = 1 unit = 8 g of ethanol.
b. Scores from 710 (low) to +10 (high).
c. Alcohol Problems Questionnaire, common scale; scores from 0 (low) to 23 (high).
d. Scores from 0 (low) to 60 (high).
e. Scores from 0 (low) to 100 (high).
f. Scores from 0 (low) to 100 (high).
g. Scores from 0 (low) to 1 (high).
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of intervention (95% CI)
Alcohol consumption (previous 180 days)
Total number of drinks consumed in periodb
Drinks per drinking dayb







145.6 (–101.7 to 392.9)
1.1 (–0.9 to 3.1)
–0.7 (–1.8 to 3.2)










–0.2 (–1.7 to 1.1)
–0.3 (–1.7 to 1.1)
1.8 (0.2 to 3.3)*
Alcohol Problems Questionnaired 2.9 (0.3) 3.2 (0.3) 0.3 (-0.6 to 1.8)
Severity of Alcohol Dependence Questionnairee 5.5 (0.7) 6.1 (0.6) 0.6 (–1.4 to 2.5)
Situational Confidence Questionnairef 77.5 (1.5) 77.1 (1.3) 0.4 (–4.3 to 3.5)







–0.2 (–1.6 to 1.8)
0.6 (–4.2 to 3.0)
Health utility (EQ–5D)h 0.7 (0.1) 0.8 (0.1) –0.1 (–0.1 to 0.1)
a. Adjusted by analysis of covariance for corresponding baseline score.
b. One standard drink = 1 unit = 8 g of ethanol.
c. Scores from 710 (low) to +10 (high).
d. Alcohol Problems Questionnaire, common scale; scores from 0 (low) to 23 (high).
e. Scores from 0 (low) to 60 (high).
f. Scores from 0 (low) to 100 (high).
g. Scores from 0 (low) to 100 (high).
h. Scores from 0 (low) to 1 (high).
*Significant at 50.05 level.
Table 4 Intervention costs per participant (£ sterling) associated with each group
Intervention group, £ per participant Control group, £ per participant
Opportunistic screening costs for 1794 screened
General lifestyle questionnaire





Minimal intervention brief advice










Step 1: motivational interview
Training cost for practice nurses
40-minute interview, including staff and premises costc
Follow-up telephone call









Step 2: motivational enhancement therapy
Four 50-minute sessions with therapist, including premises
Therapist’s administration timed







Step 3: specialist alcohol services, specialist intervention33 735.00 0.00
a. Includes salary, National Insurance, superannuation and 8% management cost.33
b. Premise size of 8m2 at £0.54/m2/hour for 5 minutes.33
c. Actual training cost £8000 divided by 54 participants.
d. 10 minutes per session.
Table 5 Mean (s.d.) costs in £ sterling for each group at baseline and 6-month follow-up (patients with follow-up data only)
Intervention group (n=51), mean (s.d.) Control group (n=39), mean (s.d.)






















Treatment 215.84 (113.08) NA 20.02 NA
NA, not applicable.
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which includes an allowance for the victim’s costs of crime. In the
intervention group, mean total costs were £5692 at baseline and
£2534 at follow-up, compared with £6851 and £12 637 in the con-
trol group. At 6 months, the intervention group had a mean
0.3849 QALYs compared with 0.3876 in the control group, a
difference of 0.0027 (95% bootstrapped 95% CI –0.0535 to
0.0500). Patients in the control group gained 0.0074 QALYs
between baseline and follow-up compared with a decrease of
0.0046 in the intervention group. A cost-effectiveness acceptability
curve40 was constructed, which indicated that stepped care had
the greater probability of being the most cost-effective inter-
vention, provided that the value of a QALY was less than
£912 000. This result suggests that at an acceptable value of a
QALY, between £20 000 to £30 000 in the UK, stepped care would
be 98% likely to be the most cost-effective option.
Discussion
Summary and relevance of findings
A total of 1794 male attendees at primary care practices were
screened using the AUDIT questionnaire. Twenty-five per cent
scored positive for hazardous or harmful alcohol consumption,
an indication of the prevalence of alcohol use disorders in this
population. We have demonstrated the high level of sensitivity
and specificity of the AUDIT in this population.41
Our study showed that it was feasible to implement a stepped
care intervention in this population. Alcohol consumption
reduced in both groups following intervention in this non-
treatment-seeking population. Differences in terms of actual
alcohol consumed were greater, but not significantly, in the
intervention group, with an effect size difference in the order
of 0.23 and 0.27 for mean daily and total alcohol consumed.
These effect sizes are comparable with those found in meta-
analyses of brief alcohol interventions.10 This will be helpful in
designing a definitive trial of stepped care intervention and for
meta-analysis. Secondary outcomes indicated a similar trend
towards better outcomes for the intervention group but none of
these was significantly different except for greater motivation to
change, which is consistent with the motivational intervention
approaches used in the intervention group. However, from
this pilot study it is not possible to conclude with confidence
that stepped care intervention is superior in terms of clinical
effects to minimal intervention because of the possibility of type
2 error.
Other limitations of the study include the relatively small
proportion of potential participants who actually gave consent
to participate (25%). We also found those who agreed to
participate were older and had higher AUDIT scores. This may
indicate that those who took part were not truly representative
of the population from which they were drawn. It may also be
the case that these differences reflect not only differences in
willingness to take part in research, but also a difference in
willingness to receive alcohol interventions if offered. In common
with other trials of brief alcohol interventions in primary care, we
excluded patients with severe mental illness on the basis that their
needs were unlikely to be met by the control intervention. In
typical practice, brief interventions are not intended for this
population except in the context of more comprehensive mental
healthcare. The pragmatic nature of the study aimed to maximise
the generalisability, and the proportion agreeing to take part is
similar to that found in meta-analysis of primary care brief
intervention studies.42 However, as we and others have pointed
out, as a public health measure, questionnaire screening for
alcohol use disorders in primary care is highly cost-effective,
as the cost of administering the questionnaire is small and
interventions are only offered to those screening positive.41,43
We will however be exploring the reasons for non-participation,
including patient and therapist characteristics, in a subsequent
study. Further, based on the experience of this study, our
ongoing research includes a considerably reduced baseline
research assessment process to maximise willingness to
participate as this may have presented a barrier to participation.
In line with current methodological research, no collateral
measures to verify self-report were included, as collateral reports
and blood investigations are not sufficiently reliable or valid
compared with self-report obtained by the Time Line Follow-Back
interview.44
Cost-effectiveness
The cost-effectiveness analysis indicated that the stepped care in-
tervention costs ten times that of the minimal intervention (£216
v. £20) as expected. However, social costs in the control group are
greater 6 months after randomisation than in the intervention
group: the mean social cost per patient in the 6-month period
preceding follow-up was £2308 in the intervention group and
£12 617 in the control group. These costs are very variable and
not statistically significantly different. The analysis of the boot-
strapped cost-effectiveness ratios suggest that in 818 (81.8%) of
the 1000 cases, stepped care is less costly and more effective, in
165 (16.5%) cases stepped care is less costly and more effective,
in 14 (1.4%) cases stepped care is more costly and more effective,
and in only 3 (0.3%) cases stepped care is more costly and less
effective. The cost-effectiveness applicability curve shows that at
accepted values for a QALY, decision makers could have
confidence of approximately 98% that the stepped care approach
would be more cost-effective than the minimal intervention
approach. The net cost saving is almost £9000 ($15 000 USD) in
stepped care compared with minimal intervention.
As a result of this study, a large-scale pragmatic randomised
controlled trial of stepped care alcohol intervention in primary
care has begun.45 As stepped care is, in research terms, a complex
intervention, future research will need to establish the key effective
ingredients of stepped care, including the necessary duration,
intensity and content of stepped care needed to deliver effective
outcomes. This will require more complex trial design and process
measurement.
Implementation
On a practical level we found that stepped care offered a new
practical clinical approach to the treatment of alcohol use
disorders encountered in everyday primary care and a positive
inter-agency protocol shared between primary care and specialist
alcohol treatment agencies. There is a clear need for the training
of primary care staff to implement screening and deliver
behaviour change counselling interventions, which include the
need for follow-up and reviews of progress. We found that the
only way we could implement either of the two interventions
was to specifically recruit and train practice nurses rather than
seek secondment from existing practice nurse posts. This was
due to reported pressures on primary care staff in providing
existing care, and was only possible to implement with additional
funding to cover the full costs of the screening and interventions.
So there are likely to be capacity, financial and workforce issues in
implementing an alcohol-screening stepped care intervention in
the National Health Service. Stepped care appears to offer a prac-
tical clinical methodology suitable for addressing the allocation of
limited resources.
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The original ‘magic bullet’ is 100 years old
Frank Heynick
Today, even long-retired psychiatrists are unlikely to recall having seen more than some occasional cases of syphilis-induced paralytic
dementia. But not many generations earlier, ‘general paresis of the insane’ accounted for some 10% – even as much as a third – of the
admissions to mental hospitals in Europe and the USA. All that began to change on the day in August of 1909 when Paul Ehrlich fired the
first ‘magic bullet’.
Dyes
Born in 1854 to a middle-class Jewish family in Strehlen, Germany, Ehrlich came on the scene at the right time and place, for it was the dawn
of the ‘heroic age of medicine’ and, not coincidentally, an era of rapid advances in the chemical industry. While chemists were revolutionising
textile manufacturing through the development of a new spectrum of synthetic dyes such as mauve and indigo, medical microscopists,
especially in Germany, were using the new aniline stains to tease out the secrets of sub-visible life, particularly the identification and
classification of microbial pathogens.
Already as a young boy, Paul Ehrlich was fascinated by the dyestuffs and colours of the nearby Silesian textile plants. His doctoral dissertation
at the University of Leipzig introduced the concept of counterstaining in vitro and he soon went on to develop dynamic vital staining in vivo.
As professor in Berlin and Frankfurt, the physician/chemist Ehrlich pioneered the fields of haematology, serum therapy, oncology and, most
notably, the molecular side-chain theory of immunity that would be honoured with the Nobel prize.
However, the triumph for which Ehrlich would forever be remembered was yet to come. As director of the new Royal Institute of Experimental
Therapy in Frankfurt early in the new century, Ehrlich returned to his youthful dream of developing a chemotherapeutic antibiotic or, as he
called it, Zauberkugel – magic bullet.
Arsenic
Put simply: Ehrlich envisioned a very selective dye-like compound – it could even be colourless – which, when injected into the bloodstream,
would home in on specific pathogens and deliver a fatal blow, while leaving the other cells of the body undisturbed.
Arsenic could be found in the materia medica since medieval times. French, British and American scientists had recently been experimenting
on its use for combating the trypanosomes of sleeping sickness. Ehrlich joined in the hunt for a safe antimicrobial arsenical ‘dye’.
But the downside to this approach was obvious. Arsenic was, after all, the favourite poison of murderers and assassins. Ehrlich’s critics
publicly cartooned him as ‘Dr Phantasus’ and several of his master chemists quit in frustration. Ehrlich himself began questioning the value
of further investment of money, time and effort on sleeping sickness, which was, after all, a tropical disease of peripheral concern to
Europeans.
606
Then, in 1905, came the news of the discovery by the German microscopist Fritz Schaudinn of the tiny, ghostly pale, corkscrew-shaped
causative agent of syphilis Treponema pallidium. On the basis of morphological similarity Schaudinn took the dubious liberty of relating it
to the trypanosome of sleeping sickness, and therefore perhaps susceptible to similar chemotherapeutic agents.
This gave renewed vigour to Ehrlich’s quest for the magic bullet. Having already experienced several hundred failures, he was ready to
tolerate several hundred more.
On 31 August 1909 came the breakthrough, as the 606th arsenical compound rapidly cured a rabbit of syphilis and produced no side-effects.
There followed tests with a few human patients and subsequently a historically unprecedented clinical trial with 65 000 doses. The overall
results were astounding. Only then was Salvarsan (the trade name, meaning ‘safe’ or ‘saving arsenic’) put on the market.
Within a decade, the incidence of syphilis in many countries was slashed by three-quarters and more. Most important from the psychiatric
standpoint: admissions to mental hospitals of patients with neurosyphilis were beginning to be a thing of the past.
The magic bullet, let it be said, was not free from backfiring: liver and kidney dysfunction and occasional fatal shock. Yet Salvarsan – and
Ehrlich’s later variant, Neosalvarsan – would remain the treatment of choice for syphilis until the advent of penicillin in the Second World War.
Dream
In today’s post-industrialised world, the challenges facing medicine – cardiovascular disease, cancers, genetic defects, and geriatric care – are
more complex than the targeting of pathogens in the heyday of the ‘microbe-hunters’. This is all the more so with regard to the array of mental
and psychosomatic afflictions confronting so many members of our society.
Yet the dream lives on of chemotherapeutic wonder-drugs that may alleviate depression (or reverse senile dementia, or dry up various
cancers) in such a specifically targeted way as to have minimal side-effects. This is in the spirit of Paul Ehrlich and the first magic bullet created
a century ago.
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